HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.

Abstract
Human MCs are primary effectors implicated in immune surveillance and defense by secreting histamine and various inflammatory mediators, a mechanism termed as degranulation. MCs can be activated by two pathways: IgE-dependent classical pathway and the IgE-independent pathway that utilizes various cationic molecules including substance P (SP) and pituitary adenylate cyclase-activating polypeptides, which are host defense peptides collectively known as basic secretagogues. Our pharmacological study investigated whether or not IgE-independent MC activation is mediated via MRGPRX2. We identified two novel MRGPRX2 antagonists, which completely inhibited the degranulation of human cord blood-derived MCs (hCMCs) induced by basic secretagogues and pseudoallergic drug, icatibant, but IgE- or A23187-challenged hCMCs were resistant to MRGPRX2 antagonists. The MRGPRX2 antagonists markedly inhibited the de novo synthesis of SP-induced prostaglandin D2 in hCMCs. Moreover, the antagonists were able to inhibit p42/44 mitogen-activated protein kinase signal in hCMCs activated by SP. This study strongly suggests that MRGPRX2 antagonists may be a promising drug to prevent the IgE-independent allergic reactions, and thus, MRGPRX2 antagonist development may lead to a promising therapeutic medication for the IgE-independent allergic reactions.
AuthorsHiroyuki Ogasawara, Masahiro Furuno, Koji Edamura, Masato Noguchi
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 106 Issue 5 Pg. 1069-1077 (11 2019) ISSN: 1938-3673 [Electronic] England
PMID31299111 (Publication Type: Journal Article)
Copyright©2019 Society for Leukocyte Biology.
Chemical References
  • MRGPRX2 protein, human
  • Nerve Tissue Proteins
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Immunoglobulin E
  • Calcimycin
  • icatibant
  • MAPK1 protein, human
  • MAPK3 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Bradykinin
Topics
  • Bradykinin (analogs & derivatives, pharmacology)
  • Calcimycin (pharmacology)
  • Fetal Blood (cytology, immunology)
  • Humans
  • Immunoglobulin E (immunology)
  • Mast Cells (cytology, immunology)
  • Mitogen-Activated Protein Kinase 1 (immunology)
  • Mitogen-Activated Protein Kinase 3 (immunology)
  • Nerve Tissue Proteins (antagonists & inhibitors, immunology)
  • Receptors, G-Protein-Coupled (antagonists & inhibitors, immunology)
  • Receptors, Neuropeptide (antagonists & inhibitors, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: